FDA Approves Tablet Formulation of Zanubrutinib for All Indications
Pharmacy Times
JUNE 11, 2025
Package insert. FDA approves tablet formulation of BeOne's BRUKINSA for all approved indications. News Release. Released June 11, 2025. Accessed June 11, 2025. BeiGene USA, Inc.; Accessed June 11, 2025.
Let's personalize your content